Medicus Pharma Ltd. (MDCX)
NASDAQ: MDCX · Real-Time Price · USD
2.020
-0.080 (-3.81%)
Aug 14, 2025, 11:56 AM - Market open

Company Description

Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets.

It develops SkinJect for the treatment of basal cell carcinoma. The company was founded in 2015 and is headquartered in Toronto, Canada.

Medicus Pharma Ltd.
Medicus Pharma logo
CountryCanada
Founded2008
IndustryDrug Manufacturers - General
SectorHealthcare
CEORaza Bokhari

Contact Details

Address:
One First Canadian Place, Suite 3400
Toronto, ON M5X 1A4
Canada
Websitemedicuspharma.com

Stock Details

Ticker SymbolMDCX
ExchangeNASDAQ
Reporting CurrencyUSD
CIK Code0001997296
ISIN NumberCA58471K2020
Employer ID98-1778211
SIC Code2834

Key Executives

NamePosition
Dr. Raza Bokhari M.B.A., M.D., MBAChief Executive Officer and Executive Chairman
James P. Quinlan CPAChief Financial Officer
Dr. Edward J. Brennan Jr., F.A.C.S., FACS, M.D.Chief Scientific Officer and Head of Research & Development Program
Carolyn BonnerPresident
Andrew Alasdair SmithChief Operating Officer
Anna Baran-Djokovic J.D.Senior Vice President of Investor Relations
Viktoriia SlepeniukSenior Vice President of Public Relations
Dr. Faisal Mehmud M.D.Chief Medical Officer
Maryann AdessoChief of Staff and Corporate Secretary

Latest SEC Filings

DateTypeTitle
Aug 12, 2025SCHEDULE 13G/AFiling
Aug 12, 2025SCHEDULE 13G/AFiling
Aug 12, 2025424B3Prospectus
Aug 12, 2025424B3Prospectus
Aug 12, 2025253G2Acc-no: 0001493152-21-027927 (33 Act)
Aug 12, 2025424B3Prospectus
Aug 11, 202510-QQuarterly Report
Aug 4, 20258-KCurrent Report
Jul 30, 20258-KCurrent Report
Jul 23, 2025424B3Prospectus